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A central goal in chemical biology is to gain control over 
biological pathways using small molecules, and the mRNA- 
synthesizing machinery is a particularly important target. New 
advances in our understanding of transcriptional regulation 
suggests strategies to manipulate these pathways using small 
molecules. 
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Introduction 
Perhap the mo5t important regulators nCt\\ orb in 
cukar)-otic cells are those that control the x_Ti\ it! of the 
niRS.\-s\ nthcsizing machinery. \\ hich incluclcs KS.\ 
polyncrasc 11 and ;I host of gentxll tranwription f:tc.tor\. 
l’his is Ixcause the expression of the \;IsI niaJority of 
c~ikqotic genes is controlled :it the Ic\cl of tr;lnscriprion 
13~ ;lcti\ 3tors and reprwsors. Such prolcins function in 2 
[Jene-specific fashion to up-rcgulatc or clo\\ n-rcqil:itc. ,5 
re\pwti\ ely. rhc :ibility of the transcriprional ni;ichincr\ to 
s\nrhesix niKSX cncodcd by the t:ii-get gcnc. In turn. 
the xxi\ irics of tr~inscriprioi~al &I ;i[ors ~itici rcpi-c4hors 
3rc usualI\ regulukxi 1~~ signal transcluction cascades th:it 
t-r:insfcr inforni:ition from the ccl1 nicn~bratic to the 
nucleus. ‘I‘hc ultinxitc go21 of n~olcculai- mctiicinc i\ to 
giin con1i-01 o\ cr tlicsc proccsscs 2nd turn particiihr gcncs 
on or off Lit \\ill. (:heniical t)iolog:\ rcprcscnts one of rhc 
tbo most proniisiqg approxhes to :ichie\ c this goal. the 
other kin:: gcnc therapy. 
‘I‘hc 21x2 of small-molecule-regillated gent e\pxhsion is 
rc\ ic\\ cd hi&>- in this article. First. the \[;itc of the xi-t of 
the field is dixvsscd. focusing on \\ork cai-ricd 0uT using 
clcri\ 3ti\ cs of naturally occurring imiiiiliios~ip~,r~~~~iiit~. 
‘I‘hcn. tllc co~llplc\- prowin niachincrv th:it niediarcs 
niliY.\ s\nthcsis iii cukar\otic cells is discu5se~l. follo~e~i 
t)) 3 brief rc\ ic\\ of the n:it~irc of the :icti\ ;Itor\ anal Ircprcb- 
sol-s their ircgiilatc the 3cti\ it\ of the tr~in~~ril,rioii~il michin- 
erb-. \\.c then consider potcnti:ll approacht3 to t‘indinp 
small niolcclilcs that \Ioulci allo\\ one to nianil>ularc rlic 
interxxions of nati\x transcription tktoi-s :incl signal-traiis- 
duction proteins \\ itli one another and \\ irh niiclcic acids. 
Finall>. \\c ccmsidcr possibilities for the A, /10x/ \\ nthchis 
of sni:i11 molcculcs that ~311 Iregulate transcril>tion tlircctl\ 
lx acting ;IS xii\ :iTor or rcprtzssor inimic3. 
Natural products as regulators of gene 
expression 
All organi\nis conrain ;I lai-gc number ofgencs whose ICI cis 
of c\prcssion 21-c conrrollcd 1~~ small ~nolcc~~l~s. For 
C~;lnlple. man) gcncs in\x)l\4 in bios\nthctic p;lthn.:i\~s 
3rc fecdhack-regulated 1)) a build lip of the product of the 
path\\ ay. (:on\ ersel!. the csprcssion of carahlic gcnc5. 
sllch ~15 those their cncodc proteins in\ 011 cd in suqr 
nietalx~lisni, are stiiniilatcd trcnicndoiisl\ 1, hen tlic cell i\ 
in 2 mcciiiim rich in the corrcspondin :q sugar. Satiirc Ihcrc- 
fort uses sniall-niolcculc-conrrollcd pcnc c\l,rcssion roti- 
tinclv. In nlost of such ~35~s. hinrlin;: of the small ~~I~I~~IIIc 
to 2 mcliil,ranc-bt,Ilnd. or soineTinics solut,lc, rcccptor that 
i\ highI\- specific for IrccogniAng rhxr inolccule triggers ;I 
cax~lde that riltiniarel~ cirhcr stimtllates or inhibits the 
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Schematic view of an activator. The DNA- 
binding domain (DBD) allows the protein to 
bind in the vicmlty of the target gene. The 
attached actlvatlon domain (AD) makes 
contacts with chromatin remodeling and 
modifying complexes as well as the 
transcription complex, serving to ‘open’ the 
chromatin structure and assist association of 
the transcription complex with the promoter. 
The activities of the DBD and AD are, to a first 
approximation, separable and there is not a 
requirement for a distinct stereochemical 
relationship between the two domains. 
activity of the mRNA-synthesizing machinery at a particu- 
lar set of genes. In most cases, the ultimate recipients of 
the signals are transcriptional activators and/or repressors. 
Activators, which will be discussed in more detail belolv, 
generally- consist of quasi-separable [ I,21 DNA-binding 
and ‘activation’ domains (Figure 1). The DNA-binding 
domain allows the protein to be localized in the vicinity of 
the target gene, Lvhereas the activation domain binds 
directly to components of the transcriptional machinery or 
to chromatin-remodelling complexes, contacts that result 
in greatly increased transcription of the target genes. 
Repressors can block the activity of activators directly. for 
example by binding to the activation domain and seques- 
tering it from the transcriptional machinery, or they can 
function indirectly, for example by mediating changes in 
chromatin structure that block access of transcription pro- 
teins to the DNA. 
The balance between activators and repressors can be 
affected by small molecules in a number of ways. For 
example, the yeast Gal4 protein (Gal4p), a potent activator 
of genes involved in galactose metabolism [3], is normally 
muzzled by a specific repressor, Gal80 protein (GaHOp), 
that binds tightly to the Gal4 activation domain [4]. When 
the galactose concentration in the medium is increased, 
the sugar binds to the Gal3 signal-transduction protein, 
which then acts upon the Gal4-Gal80 complex in an ATP- 
dependent fashion to relieve the repressive effect of Gal80 
and expose Gal4p’s activation surface [S]. The result is a 
huge induction in the expression of the GAI, genes. 
This theme of small-molecule-dependent release of an 
activator from a repressive interaction is very common. For 
example, the important acti\,ator NF-lcB is sequestered in 
an inactive complex in the cytoplasm by the protein IKB. 
Exposure of cells to a variety of stimuli, including small 
molecules such as phorbol esters. results in the phosphory- 
lation and subsequent proteasome-mediated degradation 
of IKB. As a result, NF-KB is released and it moves into 
the nucleus where it binds to DNA and, in concert with 
other activators, drives the transcription of genes involved 
in a number of important processes [6], including inflam- 
mation and limb devclopmcnt. 
Another example of this type of activation mechanism of 
particular interest to chemical biologists is the action of 
the clinically used immunosuppressants FK-506 and 
cvclosporin A (&A: Figure 2). Although the examples 
given above were responses to natural stimuli, develop- 
mental signals or cellular stress, FK-506 and CsA are pro- 
duced by soil microorganisms and are not normally 
present in human cells. ‘l’hese compounds were discov- 
ered on the basis of their ability to suppress immune func- 
tion. ‘I-heir mechanism of action. which is now understood 
in considerable detail [7,8], [ ,rovides an excellent para- 
digm for the kind of molecular tool for manipulating gene 
expression that chemical biologists would like to haac. 
A crucial step in the induction of an immune response is 
the translocation of the nuclear factor of activated T cells 
(NFAT) from the cytoplasm to the nucleus of T cells, 
where it activates the transcription of several genes, 
including that encoding interleukin-2. The event that 
triggers nuclear translocation is calcineurin-mediated 
dephosphorylation of cytoplasmic NFAT (Figure 2). 
Both FK-506 and CsA interfere with this process by first 
binding with high affinity to their respecti\,e target pro- 
teins, FKBP [9] and cyclophilin [lo]. Remarkably, the 
composite surfaces of both the FKBP-FK-506 and 
cyclophilin-CsA complexes bind calcineurin tightly [l l] 
and inhibit its ability to dephosphoqlate NFAT [l&13], 
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(a) Structures of the lmmunosuppressants FK-506 and cyclosporin A 
(CsA). (b) Schematic model for the mechanism of action of FK-506 
and CsA. Each bmds an intracellular receptor (FKBP and cyclophllin, 
respectively). The protein-small molecule complexes bind and inhibit 
calcineunn, a phosphatase, which blocks dephosphorylation and 
nuclear translocation of cytoplasmlc nuclear factor for T-cell activation 
(NFAT). NFAT, along with other gene-specific transcription factors 
(unlabeled In the figure), is required for transcnption of Interleukin-2 
(IL-2) and other genes involved in generating an immune response. 
thereby blocking Ul;r\.I‘-acti\,atec intcrlcukin-2 gene 
expression. Thus. Cs:\ and lTK-.506 can be seen 2s ‘mol- 
ecular matchmakers’ that bring about the association of 
t\vo protcinr that normally do not inreract and, in so 
doing, indirectly do\vn-regulate a pxticular path\vay of 
gene expression. 
Small molecule-mediated control of gene 
expression in engineered cells 
Schreibcr, Crabtree and unvorkers [l-l] ha\re used syn- 
thetic versions of thcsc remukable natural products to 
manipulate protein-protein interactions ilr Go (l:igurc 3). 
The crux of this \+wrk is that t\vo protcins of interest arc’ 
fused 10 the protcin rcccptors for FK-506 or (:s:I (FKRt’ 
and qdophilin, rcspccti~dy) at the DNA le\2l and then 
expressed in the cell type of interest. ‘I’hc association of 
the t\vo engineered proteins can then bc triggcrcd Iq the 
addition of cell-permeable, homodimeric or heterodimcric 
constructs in \vhich two immunosupprcss~int molec~~les 
ha\x been linked covalcntly ((FK-.506)1. (:s,-\~ or FK-Cc:\) 
[ 1.51. If mere proximity of the tagged protcins. as opposccl 
to specific intcracrions, is sufficient I0 clicir :I biological 
response. then this will occur. For cxamplc, an 1TK-.500 
homodimcr (FK-1012) \vas inrroduccd into cells cngi- 
ncercd to cxprcss two fusion proteins, one in which Flil31’ 
was linked to the acti\ ation domain of ;I transcription 
f’dctor (iYF.31.1) and another in u hich F1*;131’ nas fused to 
the DNA-binding domain of ;t transcription factor ((GF.5 or 
HF3). As transcripConal activation requires physical 
linkage of DN.A-binding and activation domains (xc 
abo\ e). but not any sort of specific intcraccion bctwccn 
these domains, FK-1012-indruxi association of these 
fusion prowins rcsultcd in the transcription of the othcr- 
wise silent urgct genes [16]. Related chemically indrlccd 
dimerization experiments hake been performed using 
fusions of FKHP or cyclophilin with signal transduction 
f’actors, such ;IS the Fas and ‘I’(:K cell-surfwe receptors 
Raf. Src or SOS. ‘l’hese experiments that manipulate signal 
transduction fGctors also result in the control of gcnc 
expression, but intervene at a point FJr upstream of the 
actual uanscription machinery. 
‘I’hese experiments illustraw the exciting potential of 
using small molecules to control gene expression in Ii\ ing 
cells. ‘I’hey promise to allow scicnrists and doctors to turn 
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Manipulation of chimerrc transcription factors 
using a small molecule allows the expression 
of a reporter gene to be regulated by a cell- 
permeable small molecule. FK-1012 is a 
synthetic homodimer containing two tethered 
FK-506 molecules (see Figure 2a). 
specific genes on and off at will using cell-permeable mole- 
cules. As the vast majority of regulation over biological 
pathways occurs at the level of signal transduction/tran- 
scription, such a technology would revolutionize molecular 
biology and medicine. The limitation with current technol- 
ogy is that immunosuppressant-derived dimerizers can 
only allo\~ the researcher to manipulate artificial proteins in 
which an immunophilin or FKRP has been fused to the 
protein(s) of interest. .4 key goal is therefore to find com- 
pounds that can be LISC~ to manipulate the interactions of 
wild-tvpe macromolecules in nonengineered cells. 
The transcription cycle: a complex symphony 
or a Texas two-step? 
‘1’0 tackle the problem of how to manipulate the transcrip- 
tional apparatus using small molecules, it would obviously 
bc helpful to have a sophisticated understanding of how 
the mRNA-synthesizing machinery in eukaryotic cells 
works. The properties of eukaryotic transcription proteins 
have been reviewed exhaustively elsewhere [ 17,181. Onl) 
a brief overview of the process will therefore be presented 
here, with a focus on understanding what activators and 
repressors do to modulate the efficiency of transcription. 
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Figure 4 
A model for the transcription cycle in 
eukaryotic cells. When a gene is first induced, 
the chromatin structure must be ‘loosened’ 
(the nucleosome is shown as disappearing for 
simplicity; this is probably not the case), 
TFIID/TFIIA must associate with the core 
promoter and an intact holoenzyme must bind 
to the TFIID/TFIIA-DNA complex. This 
provides the first complete preinitiation 
complex. This species must then open the 
double helix to expose the template strand, 
then move away from the promoter and 
initiate mRNA synthesis. Promoter escape 
Involves hyperphosphorylation of the carboxy- 
terminal domain of the poll1 largest subunit. 
TFIID/TFIIA and the mediator fragment of the 
holoenzyme are thought to ramain at the 
promoter after poll1 and associated factors 
leave. To rebuild another transcription 
complex, only the core fragment of the 
holoenzyme must add. High-level transcription 
is the result of many reinitiation cycles. If 
TFIID/TFIIA or the mediator is lost before a 
new holoenzyme core fragment can 
associate, the system must fall back to some 
step in the initiation cycle, which is much 
slower. It is proposed that a major role of 
activators is to stabilize mediator at the 
promoter to facilitate multiple rounds of 
reinitiation. 
r 
/ 
Chromatin 
remodelling 
and modification 
I 
‘Reboot’ 
uolll holoenzyme 
I= 
- lnltlatlon 
\ 
Helix 
melting 
Reinitiation 
Promoter escape 
Chemstry & Biology 
RNA polymerase II (polII), the enzyme responsible for the promoters of many gcncs [23.2-l]. One or more of the 
the transcription of all mRNA-encoding genes, is com- TAFs might also ha1.e DNIZ-binding properties [L-27]. 
prised of 12 polypeptides and operates in concert with a ‘I’FIID, all of the general transcription factors and polI1 
large number of general transcription factors (TFIIA, must assemble on the promoter to form a prcinitiation 
TFIIB, TFIID, etc.). Perhaps the most important of these complex in order to begin a transcription cycle (Figllrc 1). 
is TFIID [19], a complex of about 13 proteins that This is followed by an ATP-dependent melting of the 
includes the TATA-binding protein (TBP) [20,21] and promoter region, allowing the polymerase to associate \vith 
TBP-associated factors (TAFs) [Z]. TBP is a sequence- the template strand. IIan)- of the protein-prntein and 
specific DNA-binding protein that recognizes the so- protein-DNA interactions used to form the complex in 
called TATA boxes (consensus: 5’-TATAAAA) present in the first place must then bc scvcrcd to allow poll1 and 
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some fraction of the preinitiation complex to escape the 
promoter and begin their march down the gene. In this 
process, the elongation complex picks up a number of 
specialized elongation accessory factors ]ZS] and also 
associates with other multiprotein complexes, for 
example the splicosomc and the excision repair machin- 
ery. The transition from a promoter-bound to an elongat- 
ing polymcrase complex involves covalent modifications, 
in particular multiple phosphorylations of the carboxy- 
terminal domain (CID) of the ~0111 largest subunit [29]. 
Finally, whatever vestige of the preinitiation complex 
remains at the promoter must accept a new, hypophos- 
phorvlated polvmerase and its attendant factors to 
rebuild a new preinitiation complex (Figure 4). This 
cycle must occur many times, because a highly active 
gene fires approximately ever); five seconds. 
‘I’he complexit)- of the transcription machinery is daunting. 
The fully formed preinitiation complex has a mass greater 
than that of a ribosome, the network of protein-protein 
interactions is only partially understood, and any or all of 
the steps in the transcription cycle could be regulated by 
activators or repressors. Fortunately, recent advances in 
this field suggest that understanding the regulation of this 
process (at least at a superficial level) may not bc as diffi- 
cult as vvas feared originally. Early biochemical experi- 
ments using purified factors had suggested that formation 
of a preinitiation complex required a host of sequential 
general transcription-factor-binding events [.%)I, leading to 
an almost palpable depression in the field regarding the 
prospects of understanding the regulation of such a compli- 
cated pathway in detail. This view has now changed dra- 
matically with the realization that the vast majority of 
transcription factors travel as large, stable complexes. One 
does not therefore have to think about dozens of individual 
association steps to build a preinititation complex, as was 
once thought. As mentioned above, TFIID is a complex of 
about 13 proteins. It associates with TFIIA, comprised of 
three polypeptides, which helps TFIID bind to DNA, pos- 
sibly by competing repressors from TBP [31,32]. hlost or 
all of the rest of the general transcription factors, polI1, and 
a class of proteins known as coactivators (see below) then 
associate in one step as parts of a huge complex known as 
the RNA polymerase II holoenzyme 133.341. TFIIB, a 
holoenzyme component, hinds to TBP [35,36]. locking the 
components of the machine together into a single piece. It 
now seems likely that assembly of the preinitiation 
complex may require only two steps: TFIID/TFIIA-DNA 
binding, followed by association of the holocnzyme with 
this complex [37] (Figure 4). 
How do activators and repressors work? 
The holocnzymc is comprised of two parts. One is the so- 
called ‘core’ that includes RNA polymerase and all of the 
other proteins required for synthesizing mRNA. The other 
is the mediator [38], a complex of -20 proteins that is 
required for the holocnzyme to respond to activators in 
d-o and iz ciw. The mediator is linked to the holocnzyme 
through the CTD [39]. There is circumstantial evidence 
that this association is lost after the first firing of the pro- 
moter: ~0111 and many associated factors mov-e down the 
gent, whereas the mediator and TFIID are thought to stay 
behind ]40,31]. This probably makes reinitiation (synthesis 
of transcripts 2-n) much more facile than initiation, 
because a stable base for formation of subsequent preinitia- 
tion complexes is present and only a fragment of the 
holoenzyme must reassociate. It is reasonable to assume 
that for highly active genes the level of mRNA synthesis is 
closely correlated with the number of reinitiation events 
for each initiation elcnt. Once the system drops out of the 
reinitiation cycle as a result of loss of TFIID or mediator 
from the promoter. it must ‘reboot’ complctelv (Figure 4), 
which is prohahly slow. Acti\,ators clearly play an important 
role in reinitiation [lo] and it is therefore reasonable to 
suggest that the major role of activators is to help to retain 
the mediator at the promoter during reinitiation. Some 
activators may also help to retain TFIID [42]. 
This mechanistic picture suggests that the Icv-el of tran- 
scription can be modulated by- the lifetimes of the 
TFIID-DNA and activator-mediator complexes to give 
greater or lesser amounts of gcnc expression. The longer- 
lived these complexes, the more rounds of reinitiation 
that will occur prior to rebooting. ‘l-his vie\+. is consistent 
with the current literature. For example, activators, such 
as Gal4p. that have very high affinities for mediator 
(C-J. Jeong, L. Sun. S.-H. Yang, T.K. and S.A. Johnston, 
unpublished ohscrvations) are unusually potent activ-a- 
tars, hut only on promoters with high affinity TATA 
boxes. hlutations in the TATA box (Y. Xic, S.-H. Yang, 
I,. Sun and T.K., unpublished ohserv,ations) or TBP [43] 
that reduce the lifetime of the complex correlate directly- 
with reduced levels of activator-mediated gene expres- 
sion in ciao. This type of information is very important to 
the chemical biologist. In addition to substantiating the 
view of activator function presented ahove, the effect of 
point mutations provides an excellent signpost indicating 
which steps in a biological process should he able to bc 
manipulated using small molecules. 
Some activators ma); also play a role in recruiting TFIID 
and/or holoenzyme to promoters through direct contacts 
with TBP during the first initiation event [44-46]. A 
number of papers have also argued that activators play a 
major role in recruiting TFIID to promoters or maintaining 
it there during reinitiation through interactions with TAFs 
[47-49]. Several recent studies indicate that this is not a 
major pathway of activation Cz aim [SO-S3]. Mutations that 
affect the rate of ‘I’FIID association with the promoter 
during initiation could increase the lag time between the 
time of induction and the onset of transcription, but would 
not have corresponding effects on steady--state transcription 
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le~~els. Of course, if initiation were very selwely crippled, 
transcription would be abolished. Thus, the transcription 
process can bc likened to a light controlled by a dimmer 
switch, in kvhich the circuit must be opened for any light to 
bc produced (initiation), but the overall output of light is 
controlled by a knob that can be set to any dcsircd level 
(number of reinitiation events per initiation). 
Of course, there are man>- cxccptions to the above picture 
and no single model will describe the mechanism of action 
of all acti\Tators. For example. genes such as I)ro.ro;nlli/cr 
Hsp70 and HI\’ genes activated by Tat [54,5S] are clearly 
regulated at the Icvcl of promoter escape [Ml. possibl>- 
through activator-mediated recruitment of a kinase that 
phosphorylates the CTD and severs the association of 
~0111 with promoter-bound proteins. Small-molecule 
inhibitors of this kinasc ha1.c been identified [57]. 
Activators and repressors also function at the level of chro- 
matin structure. Chromatin is a repressed template and the 
first order of business in transcribing a gene must be to 
‘loosen up’ the chromatin structure in order to promote 
transcription-factor hinding [.58-ho]. The loosening of chro- 
matin structure occurs through activator-mediated rccruit- 
mcnt of t\vo t)-pcs of chromatin modification/remodeling 
complexes. One class is the histonc acctyl transfcrascs 
(H.ATs), Lvhich contain proteins that acetylate lie); Iysine 
residues in the amino-terminal tails of certain histones [hl], 
In some way that is not yet understood, the covalent 
modification rcndcrs the DNA in a nuclcosome far more 
accessible to DNA-binding transcription factors. The 
importance of IIATs in gene activation is underscored b)- 
the recent demonstration that certain gene-specific tran- 
scriptional repressors act bp recruiting a histone deacety- 
last complex to the target promoter, thus shutting down 
transcription [62.63]. This is a result that is particularly 
satisfying to chemical biologists, because histone 
deacetylase \vas first purified and characterized on the 
basis of its binding to trapoxin, a small molecule that 
blocks histonc deacet);lation in ~ico [h3]. A different type 
of complex that also functions at the level of chromatin is 
typified by the S\VI/SNF chromatin remodeller in k-east 
[65-681 that somehow ‘jiggles’ core nucleosomes using 
energy derived from ATP hydrolysis to facilitate tran- 
scription-factor binding. 
Activators can recruit these complexes in two ways. One is 
through direct binding. For example, the activator \.P16 
has been shown to bind to a protein called ADA2 [W] 
u-hich is part of a multiprotein complex that also includes 
GCK.5, a potent HAT [70]. Alternatively, there are indica- 
tions that TFIID and the holocnzyme may have associ- 
ated with them proteins that have HAT and/or 
chromatin-remodelling activity [71,72], so binding of the 
activation domain to one or both of these complexes ma! 
automatically recruit these activities. 
As an aside. understanding how chromatin structure influ- 
ences transcription is an arca of tremendowi opportunit) 
for chemical biologists. Ko one has cvcn the first clue 
regarding the structural changes in chromatin structure 
brought about by acetylation or :\TP-dependent rcmodcl- 
ling. Also, there arc so many different H.ATs it seems 
likcl! that different HATS ma) alter chromatin structIIrc in 
diffcrcnt ways. so the situation is almost certainly far more 
complicated than current models ~vould suggest. ‘I’his area 
of rcscarch is crying out for new probes that will allo\~ 
imwtigators to ask and ans\ver more dctailcd clucstions. 
Finally. it is important to point out that the promoters of 
most eukaryotic gents ha\~ binding sites for more than 
one activator. Thcsc different proteins often interact \vith 
one another in synergistic fashion [73] and little or no ,qene 
cxprcssion results unless all of the acti\.ators arc hound. 
\‘ery often, this is because the proteins hind to the pro- 
moter cooperati\~ely [74-7h]. ‘1%~. another tempting 
target for manipulating transcription are the acti\2tor-acti- 
kator complexes that support coopcrati\.c binding. 
DNA-protein interactions as molecular targets 
i-\s the cxamplcs ahowz should ha1.e made clear, there are a 
number of potential strategies for manipulating the tran- 
scription process using small molcculcs. Of course. com- 
pounds that fundamentalI> alter the activity of the 
transcriptional machiner) itself. for cxamplc an inhibitor 
of ~0111 elongation, would be potent modulators of tran- 
scription but nould not he gene-specific. \Iost strategies 
hawz thcrcforc focused on compounds that target tither 
the promoter of interest itself, or the acti\ ators and rcpru+ 
sors that hind to it. ‘I’hc most obvious approach is to 
develop molecules that block activator-DN;1 or rcprcs- 
sor-DYVf\ interactions and thereby turn genes off or on 
artificiallY. Another strategy would he to find small molc- 
cules that could promote or antagonize kc)- nuclear 
protein-protein interactions in\ OIL ed in regulation. for 
example between cooperating acti\-ators, I,ct\lwn rcprcs- 
sors and histonc dcaccglascs, bctwccn rcprcssors and 
acti\,ation domains, and possihlv c\‘cn I,ct\\ccn acti\.ation 
domains and their targets in the transcription machincrv. 
Finally, for man) genes (for example those acti\atcd 6, 
IVFAT) it would bc ad\,antagcous to manipulate the acti,,- 
ity of kinases, phosphorylases or proteases that modulate 
the activity of an activator or rcprcssor or control its 
nuclear localization. In an) case, the development of pro- 
tocols to design or disco\cr small molcculcs that can 
manipulate protein-protein or protein-DNh interactiona 
is a high Ipriority for chemical biologists intcrcstcd in 
manipulating gene regulation. Some particularly intcrest- 
ing recent ad\-anccs in this area Ivill be discllssed helou. 
By far the most work has been carried out on compounds 
that bind DNA and that might scr\c as inhibitors of binding 
of proteins to overlapping sites. In particular. t\\‘o types of 
R136 Chemistry & Biology 1998, Vol 5 No 6 
Figure 5 
(a) 
i H H+ l.-f--yN-N,- 
0 
1 ImlmPyPy-y-ImPyPyPy-P-Dp 
I 
2 ImlmPyPy-y-ImHpPyPy-P_Dp 
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3 ImlmHpPy-y-ImPyPyPy-P-Dp 
H+ 
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(b) 
Py/Py with T-A 
Py/Hp with T-A 
Hp/Py with T*A 
5’-T G G A C A-3’ 
Py/Py with A-T 
PylHp with A-T 
Hp/Py with A-T 
Base (A,C,T,G) 
PNA 
DNA-binding synthetic oligomers. (a) Structures of polyamides. Hp, 
3-hydroxypyrrole; Im, imidazole; Py, pyrrole; p, 6-alanine; 
y, y-aminobutyric acid; Dp, dimethylaminopropylamide. (b) Binding 
models for polyamides 1-3 in complex with 5’-TGGTCA-3’ and 
5’.TGGACA-3’. Filled and unfilled circles represent imidazole and 
pyrrole rings respectively; circles containing an H represent 3- 
hydroxypyrrole; the curved line represents y-aminobutyric acid; the 
diamond represents p-alanine; + represents the positively charged 
dimethyl-aminopropylamide tail group. (c) Basic structure of peptide 
nucleic acid (PNA). Parts (a,b) reproduced with permission from [861. 
compounds look very promising in this role. hi&en [77] very high affinities to complementary single-stranded 
has pioneered the development of protein nucleic acids nucleic acids (both DiYAs and RNAs), in fact better than 
(PNAs), Lvhich are oligomers that contain the standard standard oligonucleotides because of the lack of repulsive 
purine and pyrimidine bases of an oligonucleotide hut in phosphate-phosphate interactions. Indeed, a PNA comple- 
which the sugar-phosphate backbone is replaced with a mentary to one strand of a Dr\‘A duplex will invade the 
simple amide-based chain (Figure 5) [77]. PNAs hind with double helix, pair with its complement and displace the 
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‘like strand’, forming a ‘displacement loop’ [7X], at least in 
low ionic strength buffers. As might be expected, PNA 
invasion of a DNA duplex can abolish binding of a protein 
to an overlapping site and PNAs have also been employed 
as potent antisense agents. Zn oitm, P&As have proven to be 
useful reagents for manipulating transcription and transla- 
tion. I’nfortunately, PNAs are not very cell-permeable, 
which has greatly limited their use in living cells [79]. 
Recently, there have been many exciting advances in 
moving cell-impermeable molecules through cell mem- 
branes using special peptides, however [80]. It could be chat 
peptides conjugated to the appropriate PNA could be 
potent agents for manipulating gene regulation. 
The other class of molecules that shows great promise con- 
sists of the remarkable oligomers of modified iV-methylimi- 
dazoles and pyrroles developed by Dervan and coworkers 
(Figure 5) [81] (also see [82,83] for related work). These 
compounds were inspired by distamycin, netropsin and 
other minor-groove-binding natural products. It was hoped 
that, through both rational and some irrational experimen- 
tation, netropsin-like molecules could be made that would 
ha\,e greater sequence discriminatory powers than the 
natural products. which bind mainly A/T-rich regions. A 
seminal advance was the realization from nuclear magnetic 
resonance (NXIR) experiments and other biophysical 
studies that two distamycins were stacked in an ‘antiparal- 
lel’ fashion into the minor groove in these complexes [84]. 
‘l-his insight led to the development of ‘hairpin’ oligomers 
that mimicked this 21 binding mode, with \-ery high 
binding constants. Over several years, substituted imida- 
zole and pyrrole compounds were developed that allowed 
recognition of any the four natural \Vatson-Crick base pairs 
in the context of this conserved structural motif [85.86]. In 
other words, there is now a ‘code’ bp which a given imida- 
zole/pyrrole pair can be selected to bind a particular base 
pair of DNA. An imidazole/pyrrole oligomer complcmen- 
tary to any sequence of double-stranded DNA can thus be 
designed [87,88] with little more difficulty than one would 
have in coming up with an oligonucleotide complementary 
to a piece of single-stranded DNA. This work represents a 
major advance in biomolecular recognition. 
As one might expect, these compounds are potent 
inhibitors of protein-DNA interactions when minor 
groove contacts are critical for protein binding [89]. As 
most proteins make predominantly major-groove contacts, 
rhe imidazole/pyrrole oligomers will probably have to be 
elaborated to serve as generally useful inhibitors of 
sequence-specific protein-DNA interactions. There 
would appear to be many straightforward ways to accom- 
plish this. For example, a recent paper [90] describes the 
inhibition of binding of a fragment of the yeast GCN4 
protein to DNA in Z&V using a phosphate-interference 
strategy. It has been known for some time that alkylation 
of even a single key phosphate can prevent binding of 
many DNA-binding proteins to their target sites, reflecting 
the fact that interactions between cationic or polar 
sidechains and the charged DNA backbone make critical 
contributions to the negative free energy of protein 
binding. With this in mind, an imidazole/pyrrole oligomer 
designed to bind a sequence adjacent to the recognition 
site of the GCN4 protein [91] was coupled to the tripeptide 
Arg-Pro-Arg (RPR). The hope was that the cationic argi- 
nine sidechains would be brought by the oligomer into 
close proximity with phosphate groups in the GCN4-recog- 
nition site, allowing the formation of strong hydrogen bonds 
that would occlude binding of GCN4 protein (Figure 6). In 
fact, this approach worked nicely in vitro and should be 
generally useful for competing the binding of many DNA- 
binding proteins. Other strategies might have to be 
explored for applications in the living cell, however, 
because appending charged groups to the neutral oligomers 
is likely to reduce their cell permeability. Indeed, the imi- 
dazole/pyrrole oligomers are sufficiently new that they have 
not yet really been subjected to a ‘shakedown cruise’ in 
living cells, but initial experiments look very promising [89] 
and they clearly hold tremendous promise as reagents for 
the control of gene expression. In fact, it may not be neces- 
sary to modify these compounds to manipulate the binding 
of proteins in the major groove of DNA in order to regulate 
transcription in ho. This is because stable binding of TBP 
to TATA boxes is an important event in the transcription of 
a great many genes, and TBP is a minor-groove-binding 
protein [92]. Although it \vas stated above that targeting 
general transcription factors is a poor strategy to achieve 
gene-specific regulation, this is an exception because the 
DIVA is the true target. For example, although most 
TATA boxes more or less resemble the consensus 
.S’-TATAAAA3’, an imidazole/pyrrole oligomer could be 
made that recognizes only part of this site and also binds to 
a flanking sequence that is unique to the target promoter. 
As the affinity of TBP for the TATA box is very often cor- 
related directly with transcriptional output (Y. Xie, S.-H. 
Yang, L. Sun and T.K., unpublished observations, also see 
[43,93]), manipulation of the TBP-TATA interface using 
the imidazole/pyrrole oligomers may allow one to modulate, 
rather than completely abolish, mRNA production in a 
highly gene-specific fashion. 
There have been several other scattered reports of DNA- 
targeted inhibitors of specific protein binding, for 
example chimeras including carbohydrates and DNA- 
reactive small molecules [94]. Some of these appear to be 
quite promising and may emerge as important reagents in 
the future [9.5]. But no other class of molecules currently 
approaches the general utility of the PNAs and imidazole/ 
pyrrole oligomers. 
/ 
Much less work has been done on the complementary strat- 
egy for manipulating DNA-protein interactions: finding 
molecules that have high affinity for the DNA-binding 
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Figure 6 
(a) A schematic model of Arg-Pro-Arg (RPR) 
polyamides targeted to the major groove 
transcription factor GCN4. (a) The a-helical 
GCN4 dimer (yellow) is shown binding to 
adjacent major grooves [91]. The 
Arg-Pro-Arg-hairpin polyamide is shown as 
red, blue and green balls which represent 
imidazole, pyrrole and Arg-Pro-Arg amino 
acids, respectively. The blue diamond 
represents p-alanine. TAminobutyric acid is 
designated as a curved line. (b) The contacts 
between one GCN4 monomer and the major 
groove of one half-site of 5’-CTGACTAAT-3’ 
are depicted (adapted from [911). Circles with 
two dots represent the lone pairs of the N7 of 
purines, the 04 of thymine and the 06 of 
guanine. Circles containing an H represent the 
N6 and N4 hydrogens of the exocyclic amines 
of adenine and cytosine, respectively. The C5 
methyl group of thymine is depicted as a circle 
with CH, inside. Protein sidechains that make 
hydrogen bonds or van der Waals contacts to 
the bases are shown in purple and connected 
to the DNA via a dotted line. Green and purple 
plus signs represent protein residues that 
electrostatically contact the phosphate 
backbone. The residues that are predicted to 
be disrupted by an Arg-Pro-Arg polyamide 
are shown in green. (c)The hydrogen-bonding 
model of the eight-ring hairpin polyamide 
lmPyPyPyq#yPyPyPy-p-RPR bound to the 
minor groove of 5’-TGlTAT-3’. Circles with 
two dots represent the lone pairs of N3 of 
purines and 02 of pyrimidines. Circles 
containing an H represent the N2 hydrogens of 
guanines. Putative hydrogen bonds are 
illustrated by dotted lines. Py and Im rings are 
represented as blue and red rings, 
respectively. The Arg-Pro-Arg moiety is green. 
(d) The model of the polyamide binding its 
target site (bold) adjacent to the GCN4 
binding site (brackets). Polyamide residues are 
as in (a). Reproduced from [90]. 
(a) 5’ 3 
W 
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domains of key activators or repressors and therefore block 
their association with DNA. This is generally considered 
to be an even harder task than DNA recognition. 
Although broad structural families of DNA-binding 
domains certainly exist, polypeptide targets lack a single, 
well-defined architecture, which is a hallmark of the DNA 
double helix. Nonetheless, we predict that this approach 
will be a growth area in the future as chemical biologists 
begin to learn how to make molecules that bind specific 
peptide and protein sequences. 
Targeting protein-protein interactions: better 
ways to find a needle in a haystack 
Finding new molecular matchmakers or disrupters of 
protein-protein interactions is a very high priority for 
chemical biologists. Unnatural molecules that have these 
properties have been very hard to come by. Part of the 
reason for this is that pharmaceutical companies, where 
most protein-binding synthetic molecules come from, have 
traditionally concentrated on developing enzyme inhibitors 
rather than manipulators of protein-protein interactions. 
This will almost certainly change. Once these efforts are 
brought up to speed it will be critical to already have 
general assays by which libraries, combinatorial or other- 
wise, can be screened for molecules that have the property 
of interest, because rational design is unlikely to succeed in 
most cases. Although it is increasingly common to screen 
libraries for molecules that bind a given target protein, 
finding a matchmaker or disrupter is a difficult process 
because only a fraction of the molecules that bind a partic- 
ular protein will influence its interaction with other factors. 
Recently, there has been important progress in the design of 
high-throughput screens or selections designed to identify 
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Figure 7 
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(a). Schematic representation of the two-hybrid system, a genetic reconstituted and the reporter gene will be expressed at high levels. 
method used to detect protein-protein interactions. If the proteins (b). The three-hybrid assay to detect proteins that bind a given small 
fused to a DNA-binding domain and an activation domain do not molecule. The orange steroid-shaped symbol represents 
interact, then transcription of a reporter gene will be very low. If these dexamethasone. The red bullet represents FK-506. GR, glucocorticoid 
proteins do interact, however, then a functional activator will be receptor. See text for details. 
FKBP 
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those molecules with the desired matchmaker or disrupter 
function. 1Iuch of this work was inspired by systems set up 
by geneticists (who have been practising combinatorial 
chemistry of a sort for much longer than chemists have) to 
identify proteins that interact with one another. Generi- 
cally known as two-hybrid assays [96], this family of 
methods takes advantage of the fact that, in many pro- 
moter contexts, the DNA-binding and activation domains 
of an activator function more or less independently of one 
another (see [97,98] for exceptions), hut must he physically 
connected. For example, if the Gal4-activation and DNA- 
binding domains are severed and these fragments are 
expressed in a yeast strain deleted for wild-type GAI,4, no 
transcription of Gal4p-targeted genes will occur. If the 
genes encoding proteins X and Y are fused to the DNA 
encoding the severed GAL4 domains, and X and Y hind to 
one another. Gal4p activity will he reconstituted and tran- 
scription of the target genes will occur (Figure 7a). To 
make this system more convenient, strains have been con- 
structed in which activated transcription of a target gene is 
essential for cell survival, making the process a straightfor- 
ward selection for protein-protein interactions. LJsing this 
approach, it is now routine to screen genomic cDNA 
libraries fused to the activation domain for genes or gene 
fragments that encode polypeptides which hind to a partic- 
ular ‘bait’ protein fused to the DNA-binding domain [99]. 
hIany variations of this basic strategy have been reported 
for more specialized applications. Most relevant to this 
discussion are the ‘three-hybrid’ system and the ‘reverse 
two-hybrid’ system. The first, reported by 1,icitra and Liu 
[loo], is a clever method to identify the protein targets of 
biologically active natural products. The technique 
employ the same strategy of reconsituting the activity of 
a severed transcriptional activator, hut is designed such 
that a small molecule must bridge the interaction between 
the proteins fused to the DNA-binding and activation 
domains (Figure 7b). In a proof of principle experiment, 
the rat glucocorticoid receptor (GR) hormone-binding 
domain was fused to a sequence-specific DNA-binding 
domain and a cDNA library was fused to an activation 
domain. The screen was then carried out in the presence 
of a chimeric small molecule consisting of dexamethasone 
(a GR ligand) linked to FK-506. As expected, a screen for 
cells in which a reporter gene was activated resulted in 
the isolation of the gene encoding FKRP. This demon- 
strates the feasibility of using genetic screens for probing 
small-molecule-protein interactions in ai.uo. The reverse 
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Figure 8 
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The reverse three-hybrid system for detecting 
small molecules that disrupt a protein-protein 
interaction. See text for details. 
two-hybrid system is a method to select for mutations that 
abrogate protein-protein interactions [101,102]. In this 
case, the ‘reporter’ gene targeted by the reconstituted 
activator is chosen such that its expression is toxic and 
therefore can be selected against. 
Schreiber and coworkers [ 1031 have recently combined ele- 
ments of the two-hybrid, three-hybrid and reverse two- 
hybrid systems to create a convenient system for 
identifying small molecule disruptors of protein-protein 
interactions. Their approach is shown in Figure 8. As in the 
reverse two-hybrid system, yeast cells were engineered so 
that a protein-protein interaction which reconstitutes acti- 
vator function is conditionally toxic. This was accomplished 
using a standard yeast genetics trick of placing the URA3 
gene under the control of the severed activator and growing 
the cells in the presence of S-fluoroorotic acid (5FOA). 
When operated on by the URA3 gene product, S-FOA is 
transformed into a toxic substance but in the absence of 
URA3 expression it is harmless. Alternatively, expression of 
URA3 is nontoxic in the absence of 5-FOA, allowing clones 
that contain interacting proteins to be grown and propa- 
gated easily. The fusion proteins containing the DNA- 
binding domain and activation domain were placed under 
the control of the Gal4 protein. Gal4p-mediated expression 
is essentially zero when the cells are grown in glucose, but 
occurs at high levels in galactose-containing media. Thus, 
both the expression of the interacting proteins and the con- 
sequences of their interaction can be controlled by the 
experimenter. The utility of this system was demonstrated 
by taking advantage of the fact that FK-506 inhibits the 
binding of FKBP to the transforming growth factor p type I 
receptor Rl [103]. As expected, growth of yeast containing 
Rl fused to a DNA-binding domain and FKBP fused to an 
activation domain was sensitive to the presence of 5-FOA, 
but this sensitivity was abrogated by FK-506. 
Our laboratory has developed a different genetic assay 
(based on a method originally devised by Hu and cowork- 
ers [ 1041) in which two different fusion proteins, each con- 
taining the h repressor DNA-binding domain, are 
expressed in Eschic~ia cob equipped with a repressor- 
controlled green fluorescent protein (GFP) gene. The 
fusion proteins lack the normal dimerization domain of 
the Repressor. If the proteins fused to the DNA-binding 
domain interact and artificially dimerize the repressor 
DNA-binding domain, GFP expression is therefore 
blocked (C. Ackerson and T.K., unpublished observa- 
tions). If the fusion proteins do not heterodimerize, or if a 
molecule is present that blocks the interaction of the pro- 
teins fused to the repressor fragment, however, then GFP 
is expressed at high levels. These bright green cells are 
easy to identify in a background of dark cells. 
‘Spray and pray’ and the ‘squeege’: combining 
the power of combinatorial libraries and 
genetic assays 
The biological screens and selections described above are 
ideal for high-throughput screening protocols in which cells 
are introduced into the wells of 96 well (or denser) 
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microtiter plates, each of which contains a different chemi- 
cal. In this way, the entire suite of compounds possessed by 
a pharmaceutical company could be screened for match- 
maker or disrupter activity in a reasonable period of time. 
Of potentially even greater use, however, would be to apply 
these techniques to screening combinatorial libraries made 
by the split and pool method [lOS] in which each bead is 
derivatized with many copies of a unique compound. The 
trick here would be to somehow expose the 8. co/i or yeast 
reporter strain to many, many different beads in a spatially 
segregated manner so that ideally one yeast cell sees one 
bead in some kind of microincubator where the chemical 
compound can be released from the bead. This knotty 
problem has been solved elegantly in two ways. One, called 
the ‘stochastic nanodroplet’ method [106], employs the 
simple idea of mixing yeast cells and chemically modified 
beads together then spraying them as a fine mist onto an 
agar plate (Figure 9). If the flow and levels of yeast and 
beads arc controlled appropriately, the ‘nanodroplets’ 
sprayed onto the plate will contain from zero to a few beads 
(or O-1 if bead density is kept very low) per droplet as well 
as one to a few yeast cells. The nanodroplets arc now spa- 
tially segregated on the plate. If yeast growth is unimpeded, 
each nanodroplet will give rise to a yeast colony. Borchardt 
~FC//. [106] used beads linked to rapamycin \ia a photocleav- 
able linker to demonstrate that \vhen the plates were pho- 
tol! Led enough toxic rapamycin was released from the bead 
to diffuse into the yeast cells and strongly inhibit growth. In 
thcoq, the same approach could be employed using combi- 
natorial libraries of compounds attached to the beads by the 
same photolabile linker and a yeast or E. rob reporter strain 
enginccrcd to report on the state of a particular protcin- 
profcin interaction. 
The second approach [107] I a so employs spatially segre- 
gated nanodroplets as mini-incubators. In this case, 
ho\ve\,er. the bead/cell mixture is layered onto a plastic 
plate Lvith small wells that are extremely closely packed. 
‘I’hesc plates are produced by a photolithographic/imprint- 
ing technique and precoated with a substance that makes 
the bottom of the wells cell-adherent. Again, the amounts 
of beads and cells are chosen so that after the excess liquid 
is ‘squeegeed’ off the plate, the nanodroplcts that remain 
have one to a few beads and a fern cells in them. The 
ad\-antage of this technique is that the squeegee procedure 
is much more gentle than the spraying technique and cvcn 
much more fragile mammalian cells can be used in this 
format. ‘I-his combination of genetic selection and combina- 
torial chemistry technologies promises to be an extremely 
effective route to the discovery of small molecule disrupters 
and matchmakers. 
Synthetic mimics of activators and repressors 
Although almost all of the above discussion has focused on 
using small molecules to manipulate the interactions of 
transcription factors with each other and with DNA, 
Figure 9 
r 
Yeast Bead 
Formation of nanodroplets by spraying. A mixture of beads evenly 
dispersed in medium containing yeast is slowly injected into a stream 
of air forming a fine mist. When layered on to a surface such as a Petri 
dish this forms into nanodroplets. The average volume of the droplets 
is controlled by the amount of liquid applied to the surface. For a 
droplet volume of 50-200 nl it is possible to deposit 5000-8000 
droplets in the area of a Petri dish (80 cm2). The fraction of droplets 
containing beads depends on the density of beads in the medium prior 
to spraying. When a mixture of 80 pm Tentagel beads and medium are 
sprayed at a density of 14,000 beads/ml, approximately 1 Oo/, of the 
droplets contain beads. This results in 1000 bead-containing droplets 
per Petri dish. Of the bead-containing droplets we find that 88% 
contain a single bead, 10% contain two beads, 1.3% contain three 
beads, and 0.70/o contain four beads. Reproduced from [106]. 
perhaps the ultimate goal in this area is to make cetl-perme- 
able small molecules that directly mimic the activity of 
repressors or activators. Such molecules would be extremely 
valuable research tools and potentially revolutionary drugs. 
For example, a large percentage of human cancers are 
associated with a defective ~53 gene that encodes a tran- 
scriptional activator important in regulating cell-cycle pro- 
gression [log]. If a nontoxic small molecule could be made 
that would activate the transcription of the ~53 target genes, 
the impact on human health would bc enormous. Although 
this idea mighr have seemed to be pure fantasy a decade 
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(a) Imidazole/pyrrole oligomer (DNA-binding domain) 
Mediator-binding small molecule 
binding domain would be a small molecule 
selected to bind tightly to the mediator 
fragment of the poll1 holoenzyme. This should 
act as an artificial activation domain. (b) A 
poll1 + synthetic repressor could be constructed by 
associated fusing a pyrrole/imidazole oligomer to a small 
factors molecule that binds to, but does not inhibit, 
histone deacetylase. This would result in a 
highly inaccessible template in the region 
around the small-molecule-binding site, 
thereby strongly repressing transcription. 
Figure 10 
Proposed scheme to make completely 
synthetic activators and repressors. (a) A 
synthetic activator could be constructed from 
a Dervan-type pyrrolelimidazole oligomer 
targeted to a sequence just upstream of the 
target gene. Fused to the artificial DNA- 
‘Open chromatin’ 
‘Closed chromatin’ 
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ago, some of the advances in our understanding of transcrip- 
tional regulatory mechanisms suggest that the development 
of such a mimic is now eminently feasible. Transcriptional 
regulators appear mainly to be matchmakers between spe- 
cific DNA sequences (promoters) and either the transcrip- 
tional machinery itself or catalytic activities that condense 
or decondense the chromatin structure. Making synthetic 
mimics of transcriptional regulatory proteins should there- 
fore be orders of magnitude simpler than making small 
molecules with catalytic activities comparable to enzymes 
(for an intriguing study directed towards the creation of an 
artificial coactivator, see [109]). 
As described above, the major role of many activators is 
probably to recruit the ~0111 holoenzyme to the promoter 
and, perhaps more importantly, retain the mediator frag- 
ment there through many rounds of transcription. In 
theory, one could therefore make a synthetic activator by 
linking a sequence-specific DiXA-binding molecule, for 
example the appropriate imidazole/pyrrole oligomer, with 
a molecule selected to bind to a surface-exposed mediator 
constituent (Figure 10). At least in yeast, most of the 
mediator components have been identified and the genes 
cloned [llO], so this is quite feasible. Comparable informa- 
tion on the human mediator will undoubtedly be available 
in the near future. 
Similarly, the recent discovery that many repressors func- 
tion mainly to recruit a histone deacetylase complex to a 
given gene suggests a straightforward method to make an 
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artificial repressor. Again an imidazole/pyrrole ohgomer 
could be used to localize a covalently linked histone- 
deacetylase-binding molecule isolated from a library. In 
this case, the mammalian histone deacetylase is known 
[64] (see discussion above), and it would not surprise us if 
exactly this sort of experiment is underway is several labo- 
ratories. In fact, we predict that, if the imidazole/pyrrole 
oligonucleotides, or possibly PNAs, prove to be generally 
useful in _;& (i.e., artificial DNA-binding domains are 
readily available), within S-10 years biological chemists 
will have in hand an arsenal of small, cell-permeable mole- 
cules with which they can artificially control the expres- 
sion of a very significant fraction of genes in the human 
genome. These are exciting times. 
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